Johnson M A, Roberts E F, Mueller T. "一种的合成方法" [P]. US Patent, US 9933331 B2, 2020-07-19.
发明人黄志刚,徐明华,罗永刚. "Method for the Synthesis of 4-[2-(4-Chlorophenyl)acetyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid" [P]. 中国发明专利, 专利号 CN 115633615 B, 授权公告日 2015-08-27.
Rossi M, Schröder R, Martínez F. "A Process for Preparing High-Purity 4-[2-(4-Chlorophenyl)acetyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid" [P]. European Patent, EP 3071823 A1, 2020-10-11.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2025, 2453, (7), 78-97.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2016, 2052, 5800-5825.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 4-[2-(4-Chlorophenyl)acetyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid Using HRMS and NMR". Anal. Methods, 2025, 2113, 1221-1243.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2020, 1162, (1), 5305-5315.